Therapeutic strategies for chronic myeloid leukemia in the chronic (stable) phase

This publication has 52 references indexed in Scilit:

• Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
  New England Journal of Medicine, 2003
• Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
  New England Journal of Medicine, 2002
• Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic responders
  Blood, 2001
• Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
  New England Journal of Medicine, 2001
• Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
  New England Journal of Medicine, 2001
• Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation
  The Lancet, 1998
• Chronic leukemias
  CA: A Cancer Journal for Clinicians, 1994
• Characteristics of accelerated disease in chronic myelogenous leukemia
  Cancer, 1988
• Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon Alpha_Ain Chronic Myelogenous Leukemia
  New England Journal of Medicine, 1986
• BUSULFAN (1,4‐DIMETHANESULFONYLOXYBUTANE, MYLERAN): SUMMARY OF CLINICAL, RESULTS
  Annals of the New York Academy of Sciences, 1958